Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/21/2014US8865764 Compounds and methods for the treatment of cancer
10/21/2014US8865763 Methods and compositions for altering cell function
10/21/2014US8865762 Method for the treatment of bone diseases comprising colforsin daropate
10/21/2014US8865761 Regulation of cholesterol homeostasis
10/21/2014US8865758 Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
10/21/2014US8865757 Therapeutic compositions comprising imidazole and imidazolium compounds
10/21/2014US8865756 Inhibitors of HCV NS5A
10/21/2014US8865755 Dual-acting antihypertensive agents
10/21/2014US8865753 Compounds as cannabinoid receptor ligands
10/21/2014US8865752 Cytochrome P450 inhibitors and uses thereof
10/21/2014US8865751 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
10/21/2014US8865750 Small molecule inhibitors of RGS proteins
10/21/2014US8865749 Treatment and prevention of Th1 and ‘autoimmune’ diseases effected with antibiotics and/or angiotensin inhibition
10/21/2014US8865748 Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
10/21/2014US8865747 Pioglitazone for use in the treatment of adrenoleukodystrophy
10/21/2014US8865746 Methods of treating an overweight or obese subject
10/21/2014US8865745 Pyrazolone derivatives as PDE4 inhibitors
10/21/2014US8865744 (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
10/21/2014US8865743 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
10/21/2014US8865742 Intermediate compounds and processes for the preparation of quinoline derivatives such as Laquinimod sodium
10/21/2014US8865741 Aminoindane compounds and use thereof in treating pain
10/21/2014US8865740 Method of treating skin with microRNA modulators
10/21/2014US8865737 Antitumor agent for undifferentiated gastric cancer
10/21/2014US8865736 Antibacterial agents
10/21/2014US8865735 Solid forms of a pharmaceutically active substance
10/21/2014US8865734 Anti-infective compounds
10/21/2014US8865733 Medication and treatment for disease
10/21/2014US8865732 Heterocyclic compounds and uses thereof
10/21/2014US8865731 Inhibitor of analgesic tolerance
10/21/2014US8865730 Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
10/21/2014US8865729 Salt forms of a xanthine compound
10/21/2014US8865728 Combinations comprising methotrexate and DHODH inhibitors
10/21/2014US8865727 Method for treating pain syndrome and other disorders
10/21/2014US8865726 Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors
10/21/2014US8865725 Substituted imidazopyrimidin-5(6H)-ones as allosteric modulators of MGLUR5 receptors
10/21/2014US8865723 Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury
10/21/2014US8865722 Wet formulations of aripiprazole
10/21/2014US8865721 Delta opioid receptor agonist compounds
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/21/2014US8865719 Substituted heterocycles and their use as allosteric modulators of nicotinic and GABAA receptors
10/21/2014US8865718 Heterocyclic inhibitors of glutaminase
10/21/2014US8865717 Heterocyclic compounds
10/21/2014US8865716 Dihydropteridinones II
10/21/2014US8865715 Substituted 7-(1,2,3-Triazol-4-yl)-pyrrolo[2,3-b]pyrazines
10/21/2014US8865714 Piperazine compound capable of inhibiting prostaglandin D synthase
10/21/2014US8865712 Heterocyclic derivatives and their use in the treatment of neurological disorders
10/21/2014US8865710 Methods of treating proliferative diseases
10/21/2014US8865709 Aminooxazole inhibitors of cyclin dependent kinases
10/21/2014US8865708 Methods and compositions for inhibition of the transitional endoplasmic reticulum ATPase
10/21/2014US8865707 Cholesteryl ester transfer protein inhibitors
10/21/2014US8865706 Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
10/21/2014US8865704 Wnt pathway antagonists
10/21/2014US8865703 Pyridyltriazoles
10/21/2014US8865701 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease
10/21/2014US8865700 Collagen stimulators and their use in the treatment of skin
10/21/2014US8865699 Amino triazoles as PI3K inhibitors
10/21/2014US8865698 Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds
10/21/2014US8865697 Crystalline (6R,7R)-7-{2-(5-amino-[1,2,4] thiadiazol-3-yl)-2-[(Z)-trityloxyimino]-acetylamino}-3-[(R)-1′-tert-butoxycarbonyl-2-oxo-[1,3′]bipyrrolidinyl-(3E)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use
10/21/2014US8865696 Morphine and morphine precursors
10/21/2014US8865695 Steroidal compositions
10/21/2014US8865694 Topical compositions for treatment of skin conditions
10/21/2014US8865693 Prevention of infection
10/21/2014US8865692 Compositions for the treatment of gastrointestinal inflammation
10/21/2014US8865691 Pharmaceutical compositions and methods of use 4-pregenen-11β-17-21-triol-3,20-dione derivatives
10/21/2014US8865690 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents
10/21/2014US8865689 Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia
10/21/2014US8865688 Compositions and methods for treatment of bowel diseases with granulated mesalamine
10/21/2014US8865687 Preparation for the prevention and/or treatment of vascular disorders
10/21/2014US8865686 Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors
10/21/2014US8865685 Esters for treatment of ocular inflammatory conditions
10/21/2014US8865684 Morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate (GYY4137) as a novel vasodilator agent
10/21/2014US8865683 Active compound combinations having insecticidal properties
10/21/2014US8865682 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
10/21/2014US8865681 Use of lipid conjugates in the treatment of diseases or disorders of the eye
10/21/2014US8865679 Use of beta-glucans against biological warfare weapons and pathogens including anthrax
10/21/2014US8865678 Universal sensory structurant
10/21/2014US8865677 iRNA agents with biocleavable tethers
10/21/2014US8865675 Compositions and methods for silencing apolipoprotein B
10/21/2014US8865674 Antisense modulation of GCGR expression
10/21/2014US8865667 Higher-order cellular information processing devices
10/21/2014US8865666 Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
10/21/2014US8865665 Aminoglycosides: synthesis and use as antifungals
10/21/2014US8865664 Hydrophobically enhanced aminoglycosides
10/21/2014US8865663 Method for the administration of anti-cancer drugs
10/21/2014US8865662 Macrolides and their use
10/21/2014US8865661 Method of lowering glycemic index of foods
10/21/2014US8865660 Method of treating neurogenic overactive bladder in a mammal or method of treating non-psychological stress-related bladder dysfunction in a female mammal by administering at least on jasmonate
10/21/2014US8865659 Compositions for prevention or treatment of Hepatitis C virus containing ginsenoside Rg3 as an active ingredient
10/21/2014US8865652 Method of treating solid cancers with pegylated IL-10
10/21/2014US8865650 Therapy for complications of diabetes
10/21/2014US8865649 Preparation for use of aspartate and vitamin B12 or biotin for regulating ketone bodies
10/21/2014US8865646 Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
10/21/2014US8865644 Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein A-I and a mutant thereof
10/21/2014US8865641 Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways
10/21/2014US8865412 Methods and assays for oversulfated glycosaminoglycans
10/21/2014US8865235 Microbicidal and antiparasitic compositions
10/21/2014US8865234 Topical pain reliever
10/21/2014US8865233 Compositions and methods for treating Demodex infestations
10/21/2014US8865232 Method for treating ocular Demodex
10/21/2014US8865230 Compositions and methods for treating parasitic infections
1 ... 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 ... 7860